All In MedTech

FDA Clearance Tracker · P190009

OPRA Implant System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Dec 18, 2020 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Dec 18, 2020

Approved

Time to decision

623 days

Received Apr 5, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P190009
Device name
OPRA Implant System
Applicant
Integrum AB
Applicant location
MöLndal
Received
Apr 5, 2019
Decided
Dec 18, 2020
Decision
Approved
Supplements
11 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code PJY

FDA's approval statement

As written in FDA's record.

Approval for the OPRA Implant System. The device is indicated for patients who have transfemoral amputation due to trauma or cancer and who have or are anticipated to have rehabilitation problems with, or cannot use, a conventional socket prosthesis. The OPRA Implant System is intended for skeletally mature patients.The patient failed to receive benefit from socket prostheses or is expected to not tolerate socket use due to problems such as:1) Recurrent skin infections and ulcerations in the socket contact area;2) Pain;3) A short stump preventing the use of socket prosthesis;4) Volume fluctuation in the stump;5) Soft tissue scarring;6) Extensive area of skin grafting;7) Socket retention problems due to excessive perspiration; and8) Restricted mobility.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code PJY (Osseoanchored prostheses for the rehabilitation of transfemoral amputees).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Integrum AB

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.